Get the Stockscreener App
30.82
5.49%
-1.79
After Hours:
30.82
Twist Bioscience Corp stock is traded at $30.82, with a volume of 1.16M.
It is down -5.49% in the last 24 hours and down -23.47% over the past month.
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
See More
Previous Close:
$32.61
Open:
$32.5
24h Volume:
1.16M
Relative Volume:
1.00
Market Cap:
$2.35B
Revenue:
$277.49M
Net Income/Loss:
$-192.14M
P/E Ratio:
-9.1726
EPS:
-3.36
Net Cash Flow:
$-95.52M
1W Performance:
-21.46%
1M Performance:
-23.47%
6M Performance:
-32.11%
1Y Performance:
-28.66%
1-Day Range:
$30.72
$33.59
1-Week Range:
$30.72
$42.07
52-Week Range:
$30.72
$60.90
Twist Bioscience Corp Stock (TWST) Company Profile
Name
Twist Bioscience Corp
Sector
Industry
Phone
800-719-0671
Address
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
30.82 | 2.35B | 277.49M | -192.14M | -95.52M | -3.36 |
|
TMO
Thermo Fisher Scientific Inc
|
403.13 | 159.89B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.73 | 142.45B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
491.70 | 37.95B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
106.93 | 30.97B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
148.99 | 26.72B | 15.50B | 1.33B | 2.16B | 7.34 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Jun-04-24 | Initiated | Guggenheim | Buy |
| Jan-17-24 | Upgrade | Goldman | Neutral → Buy |
| Sep-27-23 | Initiated | Berenberg | Buy |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-03-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-29-21 | Initiated | William Blair | Outperform |
| Jun-04-21 | Initiated | Goldman | Neutral |
| Apr-12-21 | Initiated | Piper Sandler | Overweight |
| Feb-05-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-04-21 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-20 | Initiated | SVB Leerink | Mkt Perform |
| May-31-19 | Initiated | Evercore ISI | Outperform |
| Nov-26-18 | Initiated | JP Morgan | Neutral |
View All
Twist Bioscience Corp Stock (TWST) Latest News
Billionaire Nicholas J. Pritzker’s 8 Stocks with Huge Upside Potential - Insider Monkey
Twist Bioscience Corporation (TWST): Among Nicholas J. Pritzker’s Stock Picks with Huge Upside Potential - Yahoo Finance
Twist Bioscience and Ginkgo Bioworks update DNA supply deal - Investing.com
Twist Bioscience and Ginkgo Bioworks Revise Collaboration - Business Wire
Twist Bioscience Executives Sell Shares to Cover Tax Obligations - TradingView
Twist Bioscience: Expansion Efforts Continue To Face Challenges (NASDAQ:TWST) - Seeking Alpha
Where Twist Bioscience Stands With Analysts - Benzinga
Goldman Sachs Adjusts Price Target for Twist Bioscience (TWST) | TWST Stock News - GuruFocus
Guggenheim Reiterates Buy Rating on Twist Bioscience (TWST) with $50 Price Target | TWST Stock News - GuruFocus
Twist Bioscience (TWST) Price Target Lowered by Baird | TWST Sto - GuruFocus
JP Morgan Adjusts Price Target for Twist Bioscience (TWST) | TWS - GuruFocus
JP Morgan Adjusts Price Target for Twist Bioscience (TWST) | TWST Stock News - GuruFocus
Twist Bioscience Corporation (NASDAQ:TWST) Q2 2025 Earnings Call Transcript - Insider Monkey
Twist Bioscience (TWST) Price Target Adjusted by Analyst | TWST Stock News - GuruFocus
JPMorgan Adjusts Price Target for Twist Bioscience (TWST) | TWST Stock News - GuruFocus
Twist Bioscience Corp (TWST) Q2 2025 Earnings Call Highlights: R - GuruFocus
Twist Bioscience Corp (TWST) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic ... - Yahoo Finance
Twist Bioscience stock holds $58 target, safe from headwinds By Investing.com - Investing.com Canada
Twist Bioscience: Fiscal Q2 Earnings Snapshot - MySA
Twist Bioscience (TWST) Reports Q2 Revenue and New Business Laun - GuruFocus
Twist Bioscience stock holds $58 target, safe from headwinds - Investing.com Australia
Leerink maintains $40 target on Twist Bioscience stock - Investing.com
Twist Bioscience (TWST) Unveils DNA Storage Spin-Off and Reports Strong Q2 Growth - GuruFocus
Barclays maintains $45 target on Twist Bioscience stock - Investing.com
Twist Bioscience stock target trimmed to $50 by Evercore ISI - Investing.com
Twist Bioscience earnings missed by $0.05, revenue topped estimates - Investing.com Canada
Twist Bioscience (TWST) Q2 Earnings: Revenue Surges but EPS Falls Short - GuruFocus
Twist Bioscience Corp Q2 FY25 Earnings: Revenue Surpasses Estima - GuruFocus
Twist Bioscience (TWST) Spins Off Atlas Data Storage - GuruFocus
Earnings call transcript: Twist Bioscience Q2 2025 revenue rises, stock reacts positively - Investing.com Nigeria
TWIST BIOSCIENCE Earnings Results: $TWST Reports Quarterly Earnings - Nasdaq
Twist Bioscience (TWST) reports Q2 loss, tops revenue estimates - FXStreet
Twist Bioscience Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Twist Bioscience Q2 2025 slides: revenue grows 23%, margins approach 50% target - Investing.com
Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Twist Bioscience Announces Fiscal 2025 Second Quarter Financial Results - marketscreener.com
Twist Bioscience Spins Out DNA Data Storage As Independent Company - marketscreener.com
Twist Bioscience Corp Q2 FY25 Earnings: Revenue Surpasses Estimates at $92.8M, EPS Misses at -$0.58 - GuruFocus
Twist Bioscience Launches Atlas Data Storage as Independent Company With $155M Backing - marketscreener.com
Twist Bioscience (TWST) Reports Q2 Revenue and New Business Launch | TWST Stock News - GuruFocus
Twist Bioscience (TWST) Spins Off DNA Storage Unit as Atlas Data Storage | TWST Stock News - GuruFocus
Twist Bioscience Fiscal Q2 Loss Narrows, Revenue Rises; 2025 Sales Outlook Maintained - marketscreener.com
Twist Bioscience Spins Out DNA Data Storage as Independent Company - Business Wire
Twist Bioscience (TWST) Projected to Post Earnings on Monday - Defense World
What's Next: Twist Bioscience's Earnings Preview - Nasdaq
What To Expect From Twist Bioscience Corp (TWST) Q2 2025 Earnings - GuruFocus
Deeper Dive: Understanding Twist Bioscience Corp (TWST) Through its Various Ratios - DWinneX
Twist Bioscience: Experiencing Solid Growth But Significantly Overvalued (NASDAQ:TWST) - Seeking Alpha
How did Twist Bioscience Corp (TWST) fare last session? - uspostnews.com
Analyzing Twist Bioscience Corp (TWST) After Recent Trading Activity - knoxdaily.com
Envestnet Asset Management Inc. Acquires 19,340 Shares of Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Twist Bioscience Corp Stock (TWST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.60%
1.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):